[Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia].
作者信息
Gao Lin, Tang Chao-Shu
出版信息
Sheng Li Ke Xue Jin Zhan. 2002 Oct;33(4):335-8.
PMID:12650071
Abstract
摘要
相似文献
1
[Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia].
Sheng Li Ke Xue Jin Zhan. 2002 Oct;33(4):335-8.
2
[Risk factors for cardiovascular diseases: what is the role for homocysteine?].
G Ital Cardiol (Rome). 2007 Mar;8(3):148-60.
3
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Z Kardiol. 2004 Jun;93(6):439-53. doi: 10.1007/s00392-004-0075-3.
4
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
Cell Death Differ. 2004 Jul;11 Suppl 1:S56-64. doi: 10.1038/sj.cdd.4401451.
5
Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
Med Sci Monit. 2003 Apr;9(4):PI19-24.
6
Homocysteine: the latest risk factor for heart disease.
Dimens Crit Care Nurs. 2000 Jan-Feb;19(1):22-8.
7
Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Hemodial Int. 2007 Apr;11(2):210-6. doi: 10.1111/j.1542-4758.2007.00171.x.
8
Homocysteine and atherothrombosis.
N Engl J Med. 1998 Apr 9;338(15):1042-50. doi: 10.1056/NEJM199804093381507.
9
Diabetes mellitus and hyperhomocysteinemia.
Semin Vasc Med. 2002 Feb;2(1):87-95. doi: 10.1055/s-2002-23099.
10
Homocysteine, B vitamins, and cardiovascular disease.
N Engl J Med. 2006 Jul 13;355(2):206; author reply 209-11.
Zotero 插件